We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

177 hedge funds and large institutions have $1.87B invested in Regenxbio in 2018 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 51 increasing their positions, 33 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

252% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 23

180% more capital invested

Capital invested by funds: $668M → $1.87B (+$1.2B)

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

55% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 33

48% more funds holding

Funds holding: 120 → 177 (+57)

44% more call options, than puts

Call options by funds: $15.3M | Put options by funds: $10.6M

10.83% more ownership

Funds ownership: 70.66% → 81.49% (+11%)

Holders
177
Holders Change
+57
Holders Change %
+47.5%
% of All Funds
4.05%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
81
Increased
51
Reduced
33
Closed
23
Calls
$15.3M
Puts
$10.6M
Net Calls
+$4.7M
Net Calls Change
+$3.73M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$95.4M
2
WM
WS Management
Florida
+$40.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$27.4M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$20.8M
5
HCM
Highline Capital Management
New York
+$16.7M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$35.6M
2
RG
Redmile Group
California
-$27.2M
3
PHS
PFM Health Sciences
California
-$23.7M
4
JP Morgan Chase
JP Morgan Chase
New York
-$19M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$18.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
PFBT
176
Parkside Financial Bank & Trust
Missouri
$1K +$907 +19 New
PHS
177
PFM Health Sciences
California
– -$23.7M -793,951 Closed
MWNA
178
Marshall Wace North America
New York
– -$6.68M -223,901 Closed
Renaissance Technologies
179
Renaissance Technologies
New York
– -$4.01M -134,200 Closed
SFM
180
Sphera Funds Management
Israel
– -$2.98M -100,000 Closed
Two Sigma Investments
181
Two Sigma Investments
New York
– -$1.84M -61,637 Closed
AGA
182
Altrinsic Global Advisors
Connecticut
– -$1.79M -60,000 Closed
HCM
183
Highbridge Capital Management
New York
– -$1.79M -60,000 Closed
SCA
184
Secor Capital Advisors
New York
– -$1.62M -54,350 Closed
CLCM
185
Crawford Lake Capital Management
New Jersey
– -$1.15M -38,569 Closed
OAM
186
Oxford Asset Management
United Kingdom
– -$949K -31,798 Closed
6CM
187
683 Capital Management
New York
– -$746K -25,000 Closed
Susquehanna International Group
188
Susquehanna International Group
Pennsylvania
– -$997K -20,885 Closed
DZ Bank
189
DZ Bank
Germany
– -$387K -12,978 Closed
BIM
190
Bogle Investment Management
Massachusetts
– -$315K -10,567 Closed
BFM
191
Boothbay Fund Management
New York
– -$265K -8,868 Closed
PIM
192
Partner Investment Management
California
– -$264K -8,856 Closed
TI
193
Trexquant Investment
Connecticut
– -$233K -7,815 Closed
AAP
194
Ardsley Advisory Partners
Connecticut
– -$224K -7,500 Closed
BCM
195
Bayesian Capital Management
New York
– -$220K -7,355 Closed
Simplex Trading
196
Simplex Trading
Illinois
– -$203K -4,252 Closed
PAM
197
Panagora Asset Management
Massachusetts
– -$37K -1,242 Closed
TRCT
198
Tower Research Capital (TRC)
New York
– -$23K -756 Closed
SWP
199
Stratos Wealth Partners
Ohio
– -$7K -225 Closed
VCM
200
Versant Capital Management
Arizona
– +$430 +9 New
4 5 6 7
8

RGNX Hedge Fund Activity: Q2 2018 in Review

177 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q2 2018, worth a combined $1.87B — up 180% from $668M a quarter earlier.

Buyers outnumbered sellers: 81 funds opened new RGNX positions and 23 closed out — a net gain of 58 holders — while 51 added to existing stakes and 33 trimmed.

The largest buyer was BlackRock, adding an estimated $95.4M. The largest seller was Citadel Advisors, cutting an estimated $35.6M.

  • 177 institutional investors held Regenxbio (RGNX) as of Q2 2018, up from 120 in Q1 2018.
  • Funds reported $1.87B of Regenxbio stock for Q2 2018, up 180% quarter-over-quarter.
  • 81 funds opened new Regenxbio positions in Q2 2018 and 23 closed out, a net change of +58 holders.
  • The largest Regenxbio buyer in Q2 2018 was BlackRock, an estimated $95.4M added.
  • The largest Regenxbio seller in Q2 2018 was Citadel Advisors, an estimated $35.6M sold.

Based on aggregated 13F filings for Q2 2018.